ONCODESIGN
Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.
ALONC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011766229
- LEI:
- 9695004HPDBVG72O8851
- Country:
- France
- Address:
- 20 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
Description
Oncodesign Precision Medicine is a biotechnology company specializing in precision medicine. Its mission is to develop and deliver innovative therapeutic and diagnostic solutions to treat resistant and metastatic cancers. The company utilizes a unique, patient-centric model and a proprietary technology platform to discover and advance effective treatments. This approach is centered on translational thinking, aiming to address the challenges of therapeutic resistance and metastasis evolution by focusing on unmet patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-07-01 08:45 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 457.5 KB | ||
| 2022-06-30 08:28 |
Informations privilégiées / Autres communiqués
|
French | 210.2 KB | ||
| 2022-06-13 18:00 |
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 360.0 KB | ||
| 2022-04-28 21:16 |
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 3.3 MB | ||
| 2022-04-28 21:15 |
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 413.7 KB | ||
| 2022-04-07 17:45 |
Inside Information / News release on accounts, results
|
English | 703.2 KB | ||
| 2022-04-07 17:45 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 721.3 KB | ||
| 2022-02-08 18:00 |
Inside Information / Other news releases
|
English | 418.0 KB | ||
| 2022-02-08 18:00 |
Informations privilégiées / Autres communiqués
|
French | 427.5 KB | ||
| 2022-01-27 17:45 |
Inside Information / Information on annual revenues
|
English | 540.9 KB | ||
| 2022-01-27 17:45 |
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 578.7 KB | ||
| 2022-01-05 18:00 |
Informations privilégiées / Autres communiqués
|
French | 373.0 KB | ||
| 2022-01-05 18:00 |
Inside Information / Other news releases
|
English | 375.9 KB | ||
| 2022-01-05 18:00 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 623.8 KB | ||
| 2021-11-04 18:00 |
Informations privilégiées / Autres communiqués
|
French | 486.8 KB |
Automate Your Workflow. Get a real-time feed of all ONCODESIGN filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ONCODESIGN
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ONCODESIGN via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
